Envestnet Portfolio Solutions, Inc. Repligen Corp Transaction History
Envestnet Portfolio Solutions, Inc.
- $28 Billion
- Q3 2024
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 3,516 shares of RGEN stock, worth $438,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,516
Previous 3,469
1.35%
Holding current value
$438,550
Previous $437,000
19.68%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RGEN
# of Institutions
487Shares Held
54.4MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$944 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$797 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$629 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$203 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$177 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.92B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....